Papaverine Hydrochloride Injection
Product Images NDC 14789-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Papaverine Hydrochloride (NDC 14789-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pap00 0000 01)

FDA Label Image

Principal Display Panel – 2 mL Carton Label (Pap00 0000 02)

FDA Label Image

Principal Display Panel – 2 mL Vial Label (Pap00 0000 03)

Principal Display Panel – 2 mL Vial Label (Pap00 0000 03)
Papaverine Hydrochloride Injection is a prescription medicine. This injection is made in Germany and comes in a single-dose vial of 2mL. It contains 30mg/mL of Papaverine Hydrochloride. The product should be stored at a controlled room temperature of 20° to 25°C, that is, 68° to 77°F and should be protected from light until use. The product label indicates that it is necessary to retain the product in the carton until it's time to use it. The directions for use are in the package insert. The medicine is manufactured for Nexus Pharmaceuticals Inc, located in Lincolnshire, IL 60069. The LOT is unspecified, while the expected expiry date indicated as MM/YYYY.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.